The global Cell Therapy Development and Manufacturing Services market size is predicted to grow from US$ 1384 million in 2025 to US$ 3866 million in 2031; it is expected to grow at a CAGR of 18.7% from 2025 to 2031.

Cell therapy refers to the treatment or prevention of disease by infusing cells that are selected, manipulated or altered in vitro. This report focuses on the cell therapy development and manufacturing services market. Cell therapy development and manufacturing services refer to the process of providing research and development, manufacturing and related services for cell therapy, aiming to promote the development of the cell therapy field, meet patient needs, and promote industrial upgrading.

United States market for Cell Therapy Development and Manufacturing Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Cell Therapy Development and Manufacturing Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Cell Therapy Development and Manufacturing Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Cell Therapy Development and Manufacturing Services players cover AGC Biologics, AmplifyBio, Charles River Laboratories, Thermo Fisher Scientific, FUJIFILM Cellular Dynamics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Cell Therapy Development and Manufacturing Services Industry Forecast” looks at past sales and reviews total world Cell Therapy Development and Manufacturing Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Cell Therapy Development and Manufacturing Services sales for 2025 through 2031. With Cell Therapy Development and Manufacturing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy Development and Manufacturing Services industry.

This Insight Report provides a comprehensive analysis of the global Cell Therapy Development and Manufacturing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Therapy Development and Manufacturing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Therapy Development and Manufacturing Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy Development and Manufacturing Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy Development and Manufacturing Services.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy Development and Manufacturing Services market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Stem Cell Therapy
    Somatic Cell Therapy

Segmentation by Application:

    Pharmaceutical Company
    Research Institute

This report also splits the market by region:

    Americas

        United States
        Canada
        Mexico
        Brazil

    APAC

        China
        Japan
        Korea
        Southeast Asia
        India
        Australia

    Europe

        Germany
        France
        UK
        Italy
        Russia

    Middle East & Africa

        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    AGC Biologics
    AmplifyBio
    Charles River Laboratories
    Thermo Fisher Scientific
    FUJIFILM Cellular Dynamics
    Wuxi AppTec
    KBI Biopharma
    Lonza
    Catalent Biologics
    Oxford BioMedica
    GenScript
    Cell-Easy
    SK pharmteco
    RoslinCT
    Cell and Gene Therapy Catapult
    Cell Therapies
    Minaris Regenerative Medicine
    MEDINET